Curevac share price logo

Curevac Share Price

NASDAQ: CVAC

Small Cap

$5.33

-0.06

(-1.11%)

as on

Curevac Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $5.32
    $5.4
    downward going graph

    0.19%

    Downside

    1.31%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.37
    $5.72
    downward going graph

    55.53%

    Downside

    7.32%

    Upside

    downward going graph

Curevac share price movements today

Previous Close
$5.39
Open
$5.39
Volume
1.8M
Day's Low - High
$5.32 - $5.4
52 Week Low - High
$2.37 - $5.72

Curevac Historical Returns

1 Month Return
-2.91 %
3 Month Return
-4.13 %
1 Year Return
+ 55.23 %
3 Year Return
-44.49 %
5 Year Return
-89.86 %

Curevac Stock Fundamentals & Key Indicators

Check Curevac market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

-0.655

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

5.29

Industry PE ratio

-3.773885542168675

P/B Ratio

5.2871

PEG Ratio

0

EBITDA

248.7M

Revenue (TTM)

510.5M

Profit Margin

37.93%

Return On Equity TTM

40.22%

Curevac Stock Valuation

Track how Curevac P/E has moved over time to understand its valuation trends.

Curevac in the last 5 years

  • Overview

  • Trends

Lowest (3.29x)

June 30, 2025

Industry (-3.77x)

September 13, 2025

Today (5.29x)

September 13, 2025

Highest (9.64x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 5.29x

Curevac vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Curevac with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.2B-89.86%5.2937.93%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Curevac Stock including INR - Dollar returns

The Curevac stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Curevac investment value today

Current value as on today

₹1,60,081

Returns

₹60,081

(+60.08%)

Returns from Curevac Stock

₹54,942 (+54.94%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Curevac Stock

Based on 15 analysts

BUY

66.67%

Buy

26.67%

Hold

6.67%

Sell

Based on 15 analysts, 66.67% of analysts recommend a 'BUY' rating for Curevac. Average target price of $5.39

Curevac Share Price Target

Get share price movements and forecasts by analysts on Curevac.

What analysts predicted

1.11%UPSIDE

Target Price

$5.39

Current Price

$5.33

Analyzed by

15 Analysts

Target

$5.39

Curevac target price $5.39, a slight upside of 1.11% compared to current price of $5.33. According to 15 analysts rating.

Curevac Stock's Interest Amongst Investors

Search interest for Curevac Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-20% versus previous 30 day period

Curevac Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
7
8
17
24
13
15
548
15
0
1
Gross Profit
-14
-19
-8
-33
-31
-28
524
13
0
0
Operating Income
-60
-71
-54
-89
-73
-73
368
-40
-54
-61
EBITDA
-56
-59
-38
-
-72
-65
375
-
-46
-54
Interest Expense
0
1
4
4
0
0
0
0
0
0
Depreciation
5
5
5
5
4
5
4
4
4
4
Income Before Tax
-57
-67
-48
-86
-69
-71
370
-38
-51
-59
Income Tax Expense
0
0
0
-
0
1
32
-
0
0
Net Income
-61
-73
-51
-94
-76
-78
375
-34
-56
-59
Net Profit Margin
-805.43%
-889.48%
-295.34%
-383.98%
-570.22%
-502.51%
68.44%
-226.42%
-5832.47%
-4783.94%

Curevac Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
14
19
59
116
71
58
559
Gross Profit
-5
-11
42
-152
-123
-77
449
Operating Income
-72
-99
-124
-412
-249
-274
177
EBITDA
-69
-91
-123
-386
-209
-234
209
Interest Expense
0
1
22
10
3
2
-
Depreciation
3
7
10
15
23
17
18
Income Before Tax
-71
-100
-129
-412
-249
-259
190
Income Tax Expense
0
0
0
0
0
0
28
Net Income
-81
-110
-156
-465
-263
-283
169
Net Profit Margin
-553.50%
-573.46%
-263.96%
-399.76%
-369.37%
-483.96%
30.30%

Curevac Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-67
-48
-86
-69
-72
370
-32
-51
-59
Operating Cash Flow
-64
-60
-43
-96
-89
354
-66
-41
-42
Investing Cash Flow
-14
-13
-
-5
-7
-3
-
0
-1
Financing Cash Flow
-1
-1
-1
-1
-1
-1
-1
-1
-1
Change in Cash
-79
-73
-59
-102
-97
348
-70
-43
-45

Curevac Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-100
-129
-412
-249
-260
190
Operating Cash Flow
-86
522
-733
-286
-267
101
Investing Cash Flow
28
-45
-127
-93
-55
-18
Financing Cash Flow
67
819
344
63
230
-5
Change in Cash
9
1,291
-511
-315
-93
79

Global Institutional Holdings in Curevac

Funds
Holdings
Eckert Corp
0.88%
Millennium Management LLC
0.81%
BlackRock Inc
0.49%
UBS Group AG
0.37%
GSA Capital Partners LLP
0.14%

Curevac News & Key Events

    Insights on Curevac

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 893.0K → 1.24M (in $), with an average increase of 28.3% per quarter

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 6 months, CVAC stock has moved up by 77.4%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 20.5%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 168.1%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 4 quarters, 338.04M → -59.56M (in $), with an average decrease of 61.0% per quarter

    About Curevac

    founded in 2000 as a spin-off from the university of tϋbingen in germany, curevac is a leading company in the field of mrna technology and was the first company to start clin-ical trials on mrna-based drugs. the biopharmaceutical company has more than 17 years of expertise in handling and optimizing this versatile molecule for medical purposes. the basic principle of curevac's proprietary technology is the use of mrna as a data car-rier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. the company applies its technologies for the development of cancer therapies, prophylactic vaccines and molecular therapies. since its inception, strongly backed by sap founder dietmar hopp’s dievini, curevac has received approximately $420 million (€400 million) in equity investments including an investment of the bill & melinda gates foundation of $ 52million in 2015. curevac has entered into various collaborations with multinational corporations and o
    OrganisationCurevac
    HeadquartersFriedrich-Miescher-Strasse 15, Tübingen, Germany, 72076
    IndustryHealth Technology
    CEODr. Alexander Zehnder M.B.A., M.D.
    E-voting on sharesClick here to vote

    Key Management of Curevac

    Name

    Title

    Dr. Alexander Zehnder M.B.A., M.D.

    CEO, MD & Member of Management Board

    Dr. Malte Greune Ph.D.

    COO, Member of Management Board & MD

    Dr. Myriam Mendila M.D.

    Chief Scientific Officer, Head of R&D, MD & Member of the Management Board

    Slavica Stevanovic-Heck

    Head of Human Resources

    Dr. Patrick Baumhof

    Senior Vice President of Technology

    Mr. Axel-Sven Malkomes

    CFO & Member of Executive Board

    Mr. Thaminda Ramanayake

    Chief Business Officer & Member of Executive Board

    Dr. Sarah Fakih

    Vice President of Corporate Communications & Investor Relations

    Mr. Marco Rau L.L.M., Ph.D.

    General Counsel

    Dr. Ulrike Gnad-Vogt M.D., Ph.D.

    Senior VP & Area Head of Oncology

    FAQs

    What is Curevac share price today?

    Curevac share price today is $5.33 as on at the close of the market. Curevac share today touched a day high of $5.4 and a low of $5.32.

    What is the 52 week high and 52 week low for Curevac share?

    Curevac share touched a 52 week high of $5.72 on and a 52 week low of $2.37 on . Curevac stock price today i.e. is closed at $5.33,which is 6.82% down from its 52 week high and 124.89% up from its 52 week low.

    What is Curevac's market capitalisation today?

    Curevac market capitalisation is $0.00T as on .

    How to invest in Curevac Stock (CVAC) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Curevac on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Curevac Shares that will get you 0.2814 shares as per Curevac share price of $5.33 per share as on September 13, 2025 at 1:29 am IST.

    What is the minimum amount required to buy Curevac Stock (CVAC) from India?

    Indian investors can start investing in Curevac (CVAC) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹882.70 in Curevac stock (as per the Rupee-Dollar exchange rate as on ). Based on Curevac share’s latest price of $5.33 as on September 13, 2025 at 1:29 am IST, you will get 1.8762 shares of Curevac. Learn more about fractional shares .

    What are the returns that Curevac has given to Indian investors in the last 5 years?

    Curevac stock has given -89.86% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?